查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610000

非鴉片類鎮痛貼片市場規模、佔有率和趨勢分析報告：按貼片類型、分銷管道、地區、細分市場預測，2025-2030

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

非鴉片類止痛貼片市場成長與趨勢

Grand View Research, Inc.最新報告顯示，到2030年，全球非鴉片類止痛貼片市場規模預計將達到14億美元，預測期間內複合年成長率為6.2%。推動市場的關鍵因素包括疼痛相關疾病的盛行率上升以及這些貼片提供的品種與用於緩解急性和慢性疼痛的其他形式的藥物相比具有優勢。

根據 AAPM 的數據，在美國，慢性疼痛緩解所影響的人數比癌症、糖尿病和心臟疾病的總合還要多。美國脊骨神經醫學協會估計，美國公民每年至少花費 500 億美元用於治療背部相關疾病。這些事實顯示全世界對止痛治療方法的需求日益成長。

鴉片類藥物通常被用來治療疼痛和相關病症，但大多數患者會產生依賴性和濫用。對鴉片類藥物的依賴日益增加，促使許多國家開發替代療法來緩解不適。 2017年11月，美國鴉片類藥物流行病被宣布進入國家緊急狀態。因此，各國政府要求安全有效的治療方法，以減少副作用並緩解潛在的不適，從而加速市場成長。

根據藥物濫用和心理健康服務管理局 2015 年發布的一項新研究，美國三分之一的成年人曾由醫療保健提供者開立止痛藥。報告的統計數據也顯示，這些藥物的使用量超過了香菸、雪茄和無煙煙草的總和。大多數這些口服藥物被歸類為鴉片類藥物，通常具有高度成癮性，並且很容易與其他消耗品（例如酒精或其他藥物）混合使用。人們對這些藥物相關副作用的認知不斷提高，導致了替代品的開發，例如非鴉片類鎮痛貼劑，可提供相同的治療效果並有助於疼痛管理。

非鴉片類鎮痛貼片市場報告亮點

  • 2024年，萊可鹼貼片由於其在緩解各種類型疼痛（包括神經病變鎮痛和肌肉骨骼疼痛）方面的既定功效，佔據了最大的市場佔有率，為35.0%。
  • 零售藥局在市場中佔據主導地位，2024 年銷售佔有率將達到 44.6%。市面上有多種非鴉片類止痛貼劑，無需處方即可購買。
  • 由於非鴉片類鎮痛貼片市場中的領導企業在當地存在，以及疼痛管理領域的研發不斷增加以滿足不斷成長的患者群體，北美佔據了最大的收益佔有率。
  • 由於該地區主要企業的投資增加以及印度和中國等新興國家製藥業的發展，預計亞太地區在預測期內的複合年成長率最高。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章非鴉片類鎮痛貼片市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章非鴉片類鎮痛貼片市場：貼片類型業務分析

  • 貼片類型市場佔有率，2024 年和 2030 年
  • 補丁類型細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析（按補丁類型）
  • Lidocaine貼劑
  • 雙氯芬酸鈉貼劑
  • 水楊酸甲酯貼片
  • 辣椒素貼片
  • 酮洛芬貼劑
  • 其他（草本、薄荷醇等）

第5章非鴉片類鎮痛貼片市場：通路業務分析

  • 2024 年及 2030 年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 2018-2030 年按分銷管道分類的市場規模、預測與趨勢分析
  • 零售藥房
  • 醫院藥房
  • 網路藥房
  • 其他（超級市場/大賣場、DTC）

第6章非鴉片類鎮痛貼片市場：貼片類型、通路、區域、估計與趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 按國家/地區分類，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區分類，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區分類，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 按國家/地區分類，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Acorda Therapeutics, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc
    • Endo, Inc.
    • Hisamitsu Pharmaceutical Co.,Inc.
    • IBSA Institut Biochimique SA
    • Alkermes
    • Teikoku Pharma
    • Mylan NV
Product Code: GVR-4-68038-003-3

Non-opioid Pain Patches Market Growth & Trends:

The global non-opioid pain patches market size is expected to reach USD 1.4 billion by 2030, expanding at a CAGR of 6.2% during the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain.

According to the AAPM, chronic pain affects more individuals than cancer, diabetes, and coronary heart disease combined in the U.S. Estimates from the American Chiropractic Association indicate that American citizens spend at least USD 50 billion every year on back-related ailments. These facts are indicative of the growing need for therapies to alleviate pain globally.

Opioid medications are usually sought for the treatment of pain and related disorders despite resulting in dependence and abuse in majority of patients. The rising addiction to opioid drugs has encouraged many countries to develop alternate therapies to alleviate discomfort. In November 2017, opioid epidemic in the U.S. was declared as a national emergency. Thus, demand for safe and effective therapies that ease the underlying discomfort with reduced adverse effects are sought by governments, thus accelerating the market growth.

According to a new study published by Substance Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults in America were prescribed painkillers by medical providers. Statistics from the same source also indicate that these medications were used more than cigarettes, cigars, and smokeless tobacco combined. Most of these oral medicines fall under the opiate category are usually more prone to be addictive and used in combination with other consumables such as alcohol and other drugs. Growing awareness about the adverse effects associated with these drugs has led to the development of alternatives such as non-opioid pain patches to deliver the same therapeutic effect and aid in pain management.

Non-opioid Pain Patches Market Report Highlights:

  • Licodaine patches held the largest market share of 35.0% in 2024, owing to their established efficacy in alleviating various pain types, including neuropathic and musculoskeletal pain.
  • Retail pharmacies dominated the market with a revenue share of 44.6% in 2024. A variety of non-opioid pain patches are available over-the-counter, enabling customers to purchase them without prescriptions.
  • North America held the largest revenue share due to local presence of major non-opioid pain patch market players and increasing R&D in the field of pain management to cater to a rising number of patients
  • The Asia Pacific region is expected to account for the highest CAGR during the forecast period owing to rise in investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Patch Type
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Non-opioid Pain Patches Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Non-opioid Pain Patches Market: Patch Type Business Analysis

  • 4.1. Patch Type Market Share, 2024 & 2030
  • 4.2. Patch Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Patch Type, 2018 to 2030 (USD Million)
  • 4.4. Lidocaine Patches
    • 4.4.1. Lidocaine Patches Market, 2018 - 2030 (USD Million)
  • 4.5. Diclofenac Patches
    • 4.5.1. Diclofenac Patches Market, 2018 - 2030 (USD Million)
  • 4.6. Methyl Salicylate Patches
    • 4.6.1. Methyl Salicylate Patches Market, 2018 - 2030 (USD Million)
  • 4.7. Capsaicin Patches
    • 4.7.1. Capsaicin Patches Market, 2018 - 2030 (USD Million)
  • 4.8. Ketoprofen Patches
    • 4.8.1. Ketoprofen Patches Market, 2018 - 2030 (USD Million)
  • 4.9. Others (Herbal, Menthol, etc.)
    • 4.9.1. Others (Herbal, Menthol, etc.) Market, 2018 - 2030 (USD Million)

Chapter 5. Non-opioid Pain Patches Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Retail Pharmacies
    • 5.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Online Pharmacies
    • 5.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.7. Others (Supermarkets/Hypermarkets, DTC)
    • 5.7.1. Others (Supermarkets/Hypermarkets, DTC) Market, 2018 - 2030 (USD Million)

Chapter 6. Non-opioid Pain Patches Market: Regional Estimates & Trend Analysis by Patch Type and Distribution Channel

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Acorda Therapeutics, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Teva Pharmaceutical Industries Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. GSK plc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Endo, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Hisamitsu Pharmaceutical Co.,Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. IBSA Institut Biochimique SA
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Alkermes
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Teikoku Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Mylan N.V.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global non-opioid pain patches market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 5 Global non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 8 North America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 12 Canada non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 14 Mexico non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 17 Europe non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 19 UK non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 21 Germany non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 23 France Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 25 Italy non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 27 Spain non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 29 Norway Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 31 Denmark non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 33 Sweden non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 38 Japan non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 40 China non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 42 India non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 44 Australia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 46 South Korea non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 48 Thailand non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 51 Latin America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 53 Brazil non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 55 Argentina non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 60 South Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 64 UAE non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Non-opioid pain patches market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Patch type and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Non-opioid pain patches market dynamics
  • Fig. 12 Non-opioid pain patches market: Porter's five forces analysis
  • Fig. 13 Non-opioid pain patches market: PESTLE analysis
  • Fig. 14 Non-opioid pain patches market: Patch type segment dashboard
  • Fig. 15 Non-opioid pain patches market: Patch type market share analysis, 2024 & 2030
  • Fig. 16 Lidocaine patches market, 2018 - 2030 (USD Million)
  • Fig. 17 Diclofenac patches market, 2018 - 2030 (USD Million)
  • Fig. 18 Methyl salicylate patches market, 2018 - 2030 (USD Million)
  • Fig. 19 Capsaicin patches market, 2018 - 2030 (USD Million)
  • Fig. 20 Ketoprofen patches market, 2018 - 2030 (USD Million)
  • Fig. 21 Others (herbal, menthol, etc.) market, 2018 - 2030 (USD Million)
  • Fig. 22 Non-opioid pain patches market: Distribution channel segment dashboard
  • Fig. 23 Non-opioid pain patches market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 24 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 25 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 26 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 27 Others (supermarkets/hypermarkets, DTC) market, 2018 - 2030 (USD Million)
  • Fig. 28 Non-opioid pain patches market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. country dynamics
  • Fig. 33 U.S. non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada country dynamics
  • Fig. 35 Canada non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico country dynamics
  • Fig. 37 Mexico non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 39 UK country dynamics
  • Fig. 40 UK non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany country dynamics
  • Fig. 42 Germany non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 43 France country dynamics
  • Fig. 44 France non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy country dynamics
  • Fig. 46 Italy non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain country dynamics
  • Fig. 48 Spain non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway country dynamics
  • Fig. 50 Norway non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark country dynamics
  • Fig. 54 Denmark non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan country dynamics
  • Fig. 57 Japan non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 58 China country dynamics
  • Fig. 59 China non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 60 India country dynamics
  • Fig. 61 India non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand country dynamics
  • Fig. 67 Thailand non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil country dynamics
  • Fig. 70 Brazil non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina country dynamics
  • Fig. 72 Argentina non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa country dynamics
  • Fig. 75 South Africa non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia country dynamics
  • Fig. 77 Saudi Arabia non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE country dynamics
  • Fig. 79 UAE non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait country dynamics
  • Fig. 81 Kuwait non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 82 Company categorization
  • Fig. 83 Company market position analysis
  • Fig. 84 Strategic framework